日本癌症小组测试的患者和医生偏好:最好最坏的扩展研究
Yoshiyuki Suehara1,2, Kazuo Hasegawa3, Yoshiyuki Majima4
1Department of Medicine for Orthopaedics and Motor Organ, Juntendo University Graduate School of Medicine, Tokyo, Japan.
BMJ open
|August 26, 2025
概括
日本的患者和医生非常重视综合基因组分析 (CGP), 主要负担包括高成本和长时间,为CGP流程改进提供信息.
科学领域:
- 癌症学
- 基因组学
- 医疗服务研究
背景情况:
- 综合基因组分析 (CGP) 为癌症患者提供了有针对性的治疗选择.
- 了解患者和医生的观点对于优化CGP实施至关重要.
- 这项研究重点关注日本CGP的医疗环境.
研究的目的:
- 评估与CGP相关的利益和负担的相对重要性.
- 在日本捕捉患者和医生对CGP的偏好.
- 确定影响CGP采用和实用性的关键因素.
主要方法:
- 使用最佳-最差缩放 (BWS) 和定性方法进行横截面研究.
- 在线调查对229名癌症患者和329名医生进行.
- 为量化各种CGP属性的重要性,计算了偏好分数.
主要成果:
- 患者优先考虑提供结果的测试,零自费和血液样本的使用.
- 医生们对具有保证结果的测试,血液样本和以前样本的使用进行了评价.
- 这两组都认为高成本 (80万日元) 和长时间 (3个月) 是很大的负担.
结论:
- 这些研究结果为患者和医生提供了加强CGP测试过程的见解.
- 结果可以为CGP技术和医疗保健政策的发展提供信息.
- 优化CGP需要解决患者和医生的利益和负担.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.4K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.2K
相关概念视频
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
